91
Views
10
CrossRef citations to date
0
Altmetric
Miscellaneous

α-Lipoic acid, an anti-obesity agent?

Pages 1641-1643 | Published online: 24 Feb 2005

Bioliography

  • KIM M-S, PARK J-Y, NAMKOONG Cet al: Anti-obesity effect of a-lipoic acid mediated by suppression of hypothalamic AMP-activated protein. Nat. Med. (2004) 10:727–733.
  • PEETERS A, BARENDREGT JJ, WILLEKENS F et al.: Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. (2003) 138:24–42.
  • HARDIE DG: The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology (2003) 144:5179–5183.
  • ANDERSSON U, FILIPSSON K, ABBOTT CR et al: AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. (2004) 279:12005–12008.
  • MINOKOSHI Y, ALQUIER T, FURUKAWA N et al: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature (2004) 428:569–574.
  • MUST N, HIRSHMAN MF, NYGREN J et al.: Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with Type 2 diabetes. Diabetes (2002) 51:2074–2081.
  • JACOB S, STREEPER RS, FOGT DL et al: The antioxidant a-lipoic acid enhances insulin-stimulated metabolism in insulin-resistant rat skeletal muscle. Diabetes (1996) 45:1024–1029.
  • EASON RC, ARCHER HE, AKHTAR S, BAILEY CJ: Lipoic acid increases glucose uptake by skeletal muscles of obese diabetic ob/ob mice. Diabetes Obes. Metab. (2002) 4:29–35.
  • BITAR MS, WAHID S, PILCHER SM, AL-SALEH E, AL-MULLA F: a-Lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Harm Metab. Res. (2004) 36:542–549.
  • ZIEGLER D, HANEFELD M, RUHNAU KJ et al.: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant a-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 38:1425–1433.
  • BERNKOP-SCHNURCH A, REICH-ROHRWIG E, MARSCHULTZ M, SCHUHBAUER M, KRATZEL M: Development of a sustained release dosage form for a-lipoic acid. II. Evaluation in human volunteers. Drug Dev. had. Phann. (2004) 30:35-42. Affiliation Sheila A Doggrell PhD, DSc Doggrell Biomedical Communications, 47 Caronia Crescent, Lynfield, Auckland, New Zealand E-mail: [email protected]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.